ArticleMolecular biotechnology2026
Adaptive Evolution in Aminoacyl-tRNA Synthetases Drives Antibiotic Tolerance and Resistance in Clinical Klebsiella pneumoniae Isolates.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Klebsiella pneumoniae is a major global health threat due to the rapid spread of antimicrobial resistance (AMR), which severely limits treatment options. Although horizontal gene transfer of mobile genetic elements is a key driver of multidrug resistance, this study explores how adaptive evolution within the core genome may also contribute to the clinical success of resistant strains. Using whole-genome sequencing-based pangenome analysis of clinically relevant classical K. pneumoniae isolates, we identified 3159 variants distributed across 414 core genes, indicating that even highly conserved cellular functions accumulate mutations in clinical environments. Functional enrichment analysis revealed a significant concentration of mutations in the aminoacyl-tRNA synthetase (aaRS) pathway, a central component of protein synthesis and a known antibiotic target. Multiple missense variants were detected in eight aaRS genes, with the Asn366Asp mutation in metG present in all analyzed isolates. We hypothesize that this conserved, recurrent mutation may contribute to bacterial adaptation, potentially by modulating protein synthesis, although this proposed mechanism remains speculative and requires experimental validation. Recurrent mutations were also observed in ileS and leuS, both targets of existing antimicrobials, while a Ser480Pro mutation in pyrG (CTP synthase) was identified in several isolates. Overall, these findings highlight core genome variation as a potential contributor to antimicrobial resistance in K. pneumoniae and suggest that conserved mutations such as metG Asn366Asp may represent candidate genomic biomarkers warranting further investigation. Because this study is based solely on comparative genomics, the proposed functional and mechanistic interpretations should be regarded as hypotheses for future experimental testing.
Indexed as
Identifiers
42599638What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.